Trifluoroacetic Acid

Trifluoroacetic Acid

SCHEMBL5111784

COc1ccc(-c2cccc(Cl)c2)c(NC(=O)O)c1.O=C(O)C(F)(F)F

nearest known ligand 0.52

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
AKR1C3 P42330 2/20 0.46
AKR1C2 P52895 2/20 0.46
KMT2A Q03164 5/20 0.45
MEN1 O00255 4/20 0.45
HPGD P15428 2/20 0.45
LMNA P02545 1/20 0.45
GFER P55789 1/20 0.45
SMN1; SMN2 Q16637 1/20 0.45
IDH2 P48735 2/20 0.42
ATM Q13315 2/20 0.42
FADS1 O60427 1/20 0.41
NPC1 O15118 2/20 0.41
RAB9A P51151 2/20 0.41
AKR1C4 P17516 1/20 0.41
AKR1C1 Q04828 1/20 0.41
MAPT P10636 2/20 0.41
PKM P14618 1/20 0.41
HTT P42858 1/20 0.41
KDM4E B2RXH2 2/20 0.40
ALDH1A1 P00352 2/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
Trifluoroacetic Acid SCHEMBL5107023 0.86 IDH2 (0.45) KMT2AMEN1IDH2ATMALDH1A1
SCHEMBL5111796 0.84 AKR1C3 (0.42) AKR1C3AKR1C2KMT2AMEN1HPGD
Trifluoroacetic Acid SCHEMBL5112036 0.83 IDH2 (0.45) KMT2AMEN1IDH2RAB9ACNR1
SCHEMBL16438568 0.83 KMT2A (0.53) AKR1C3AKR1C2KMT2AMEN1HPGD
Trifluoroacetic Acid SCHEMBL5099366 0.81 CNR1 (0.45) AKR1C3AKR1C2KMT2AMEN1LMNA
SCHEMBL5106389 0.80 KDM4E (0.53) AKR1C3AKR1C2KMT2AMEN1LMNA
Trifluoroacetic Acid SCHEMBL5103314 0.79 IDH2 (0.44) KMT2AMEN1IDH2RAB9ACNR1
Trifluoroacetic Acid SCHEMBL5106872 0.79 MEN1 (0.44) KMT2AMEN1SMN1; SMN2ATMRAB9A
SCHEMBL5106415 0.79 MAPT (0.51) AKR1C3AKR1C2SMN1; SMN2NPC1RAB9A
SCHEMBL5106950 0.76 CNR1 (0.48) KMT2AMEN1IDH2FADS1RAB9A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists LAINE DRAMANE I 2008-10-09 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20080249127-A1 Muscarinic Acetylcholine Receptor Antagonists CHRM3, CHRNG, CHRM2 AKR1C3 1908/4885AKR1C2 2538/4885KMT2A 2510/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.